We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Genomic Aging Study to Acquire Latest Generation Sequencing Systems

By LabMedica International staff writers
Posted on 22 Sep 2011
The next phase of a large genomic study that seeks to understand the genetic basis of age-related disorders and their risk factors will be carried out with the latest generation of automated sequencing systems.

The Rotterdam Study, which is being supervised by investigators at Erasmus University Medical Center (Rotterdam, the Netherlandsl) is a large prospective, single-center, population-based cohort study in a suburb of Rotterdam, which includes 15,000 participants aged 45 years or more who have been followed since 1990. More...
The major focus of the Rotterdam Study has been the identification of genetic risk factors for age-related disorders such as osteoporosis, cardiovascular disease, Alzheimer disease, and type II diabetes.

Recently the managers of the Rotterdam Study announced that the next phase of testing – on more than 3,000 samples – would be carried out using the latest generation automated sequencing systems. These tools will be provided by Roche NimbleGen (Madison, WI, USA) and Caliper Life Sciences (Hopkinton, MA, USA).

NimbelGen’s SeqCap EZ Library is a liquid-based enrichment technology, which enables the targeted capture for subsequent sequencing of the exome or a targeted subset of genes. SeqCap EZ Library is compatible with various sequencing chemistries and with the addition of the Caliper Sciclone NGS Workstation, provides a comprehensive high-throughput target enrichment solution.

“The automated Roche capture platform was in our case the most optimal solution to analyze these thousands of DNA samples,” said Dr. Andre Uitterlinden, head of the genetics laboratory at Erasmus University Medical Center. “It will bring the large database we have been creating over the years of the Rotterdam Study to a new and deeper level of genetic resolution, hopefully leading to further exciting discoveries in the field of complex genetics.”

“We are extremely excited to see our technologies selected for use in the Rotterdam Study,” said Frank Pitzer, CEO of Roche NimbleGen. “This sample cohort has been used to significantly advance our knowledge of age-related disorders and we are honored to have our technology adopted for use in such a comprehensive and well-organized study.”

Related Links:

Erasmus University Medical Center
Roche NimbleGen
Caliper Life Sciences



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Automated Clinical Chemistry Analyzer
Envoy 500+
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.